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Background:  Sudden cardiac death (SCD), the cause of 250,000-450,000 deaths per year, is a major public health problem. Implantable 
cardioverter defibrillator therapy confers a mortality benefit for subgroups at high risk. Recent analyses have suggested that even in high risk 
populations, women are at less risk of SCD than men. However, trials have largely enrolled women with nonischemic cardiomyopathy, pathology less 
commonly associated with SCD. We examined the effect of female sex on mode of death in a post-myocardial infarction population.
Methods:  Overall mortality and mode of cardiac death was examined in 5410 subjects enrolled (29% female) in the OPTIMAAL trial. Covariate-
adjusted Cox model regressions were used to estimate the hazard ratios of overall mortality, heart failure death or SCD by sex.
Results:  Over a median follow-up of 2.9 years, there were 932 deaths (35% in women), 329 SCD (30% in women) and 199 heart failure deaths 
(46% in women). Female sex was not associated with age-adjusted all cause mortality (HR 1.01, p=0.92). Female sex was associated with an 
increased age-adjusted risk of heart failure mortality (HR 1.45, p=0.01) and a similar risk of SCD (HR 0.86, p=0.22), compared with men. Female 
sex remained associated with a higher risk of heart failure mortality even after adjustment for related clinical characteristics and risk-factors, with 
an adjusted hazard ratio of 1.46 (95% CI 1.06-2.01: p=0.019). No increased risk of SCD in women was found after adjustment (HR 0.89, p=0.38).
Conclusion: Despite a similar risk of overall mortality and SCD, women have an increased risk of heart failure mortality after myocardial infarction 
compared with men. These findings may explain the increased benefit seen in women due to biventricular pacing, and the potentially reduced 
benefit afforded by defibrillator therapy.
